Mortality trends related to cardiogenic shock in heart failure patients aged 25 and older across the United States: a study utilizing the CDC WONDER database from 1999 to 2023
10.1016/j.ijcha.2025.101732 · doi-reference
Heart disease and stroke statistics—2019 update: a report from the American Heart Association
10.1161/cir.0000000000000659 · doi-reference
Burden of ischemic heart diseases among US states from 1990-2019
10.2174/0115701611305792240426120709 · doi-reference
Sex disparities in ischemic heart disease mortality across United States: the southern burden of excess body weight and diet
10.1161/jaha.125.043914 · doi-reference
Geographic variations in cardiovascular health in the United States: contributions of state- and individual-level factors
10.1161/jaha.114.001673 · doi-reference
CDC WONDER: trends in diabetes mellitus mortality in the United States from 1968 to 2021
10.1016/j.diabres.2025.112012 · doi-reference
Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity
10.1080/09674845.2009.11730261 · doi-reference
Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: a meta-analysis and meta-regression
10.1002/clc.23253 · doi-reference
Impact of age on endothelial function of saphenous vein grafts in coronary artery bypass grafting
10.3390/jcm12175454 · doi-reference
Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons
10.1023/a:1013797722156 · doi-reference
Impact of age on cardiovascular risk: implications for cardiovascular disease management
10.1016/j.atherosclerosissup.2004.03.006 · doi-reference
The intersection between aging and cardiovascular disease
10.1161/circresaha.111.246876 · doi-reference
Race/ethnic disparities in utilization of lifesaving technologies by Medicare ischemic heart disease beneficiaries
10.1097/01.mlr.0000156864.80880.aa · doi-reference
Improved survival for individuals with common chronic conditions in the Medicare population
10.1002/hec.4168 · doi-reference
Racial, ethnic, socioeconomic, and geographic inequities in access to mechanical circulatory support
10.1016/j.jscai.2023.101193 · doi-reference
Evaluation of gender differences in door-to-balloon time in ST-elevation myocardial infarction
10.1016/j.hlc.2013.03.078 · doi-reference
Delayed care and mortality among women and men with myocardial infarction
10.1161/jaha.117.005968 · doi-reference
Interhospital transfer due to failed prehospital diagnosis for primary percutaneous coronary intervention: an observational study on incidence, predictors, and clinical impact
10.1177/2048872613481449 · doi-reference
Estrogen and progesterone inhibit vascular smooth muscle proliferation
10.1210/endo.138.8.5354 · doi-reference
Renin angiotensin system and gender differences in the cardiovascular system
10.1016/s0008-6363(01)00479-5 · doi-reference
The protective effects of estrogen on the cardiovascular system
10.1056/nejm199906103402306 · doi-reference
Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications
10.1111/bph.12270 · doi-reference
Unlike common pneumonia, COVID-19 is a risk factor for multiple cardiovascular diseases: a two-sample Mendelian randomization study
10.1097/md.0000000000041015 · doi-reference
Allocating medical resources in the time of COVID-19
10.1056/nejmc2009666 · doi-reference
National trends in heart failure mortality in men and women, United Kingdom, 2000-2017
10.1002/ejhf.1996 · doi-reference
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
10.1016/s0140-6736(20)30566-3 · doi-reference
Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)
10.1001/jamacardio.2020.1017 · doi-reference
Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States
10.1016/j.pcad.2022.09.002 · doi-reference
Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019
10.1093/eurjpc/zwab213 · doi-reference
Plant based diet and its effect on cardiovascular disease
10.3390/ijerph20043337 · doi-reference
Sport in ischemic heart disease: focus on primary and secondary prevention
10.1002/clc.24052 · doi-reference
Global epidemiology of ischemic heart disease: results from the global burden of disease study
10.7759/cureus.9349 · doi-reference
Demographics and regional trends of ischemic heart disease-related mortality in older adults in the United States, 1999-2020
10.1371/journal.pone.0318073 · doi-reference
Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the global burden of disease study 2017
10.1093/eurjpc/zwab066 · doi-reference
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019
10.1016/s0140-6736(20)30925-9 · doi-reference
Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study
10.1016/j.jacc.2020.11.010 · doi-reference
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021
10.1016/s0140-6736(24)00757-8 · doi-reference
Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015
10.1016/j.jacc.2017.04.052 · doi-reference
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
10.1161/cir.0000000000000350 · doi-reference
Pathophysiology of coronary microvascular dysfunction
10.1253/circj.cj-21-0848 · doi-reference
